PRA Health Sciences, Inc. (PRAH) Social Stream
PRA Health Sciences Inc (PRAH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRAH.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $170 | $160 | $165.4 | $165.21 | 0.12% |
The Trend in the Analyst Price Target
PRAH's average price target has moved up $64.32 over the prior 14 months.
Over the past 14 months, PRAH's average upside potential has been 2.28%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-02 | 5 | 170 | 160 | 165.40 | 165.21 | 0.12% |
| 2021-06-16 | 8 | 175 | 160 | 167.75 | 166.44 | 0.79% |
| 2021-06-13 | 8 | 175 | 160 | 167.75 | 168.66 | -0.54% |
| 2021-06-05 | 8 | 175 | 160 | 167.75 | 170.27 | -1.48% |
| 2021-04-26 | 8 | 196 | 155 | 163.63 | 167.11 | -2.08% |
| 2021-04-25 | 8 | 196 | 155 | 163.63 | 166.80 | -1.9% |
| 2021-04-17 | 8 | 196 | 155 | 163.00 | 161.76 | 0.77% |
| 2021-03-23 | 9 | 196 | 120 | 154.33 | 147.80 | 4.42% |
| 2021-03-20 | 9 | 196 | 120 | 154.33 | 150.05 | 2.85% |
| 2021-03-13 | 9 | 196 | 110 | 149.33 | 146.65 | 1.83% |
| 2021-03-05 | 10 | 196 | 110 | 147.40 | 146.44 | 0.66% |
| 2021-02-01 | 12 | 145 | 110 | 127.42 | 124.93 | 1.99% |
| 2021-01-30 | 12 | 145 | 110 | 127.42 | 123.24 | 3.39% |
| 2021-01-23 | 12 | 145 | 110 | 126.75 | 132.26 | -4.17% |
| 2021-01-16 | 12 | 143 | 110 | 125.50 | 130.84 | -4.08% |
| 2021-01-09 | 12 | 143 | 110 | 125.17 | 129.88 | -3.63% |
| 2021-01-02 | 12 | 143 | 105 | 122.92 | 125.44 | -2.01% |
| 2020-12-04 | 12 | 143 | 105 | 122.92 | 113.71 | 8.1% |
| 2020-11-28 | 13 | 143 | 105 | 122.77 | 110.99 | 10.61% |
| 2020-11-11 | 13 | 143 | 105 | 122.77 | 107.35 | 14.36% |
| 2020-10-25 | 13 | 130 | 100 | 113.77 | 109.93 | 3.49% |
| 2020-08-11 | 13 | 130 | 100 | 113.62 | 101.38 | 12.07% |
| 2020-08-07 | 13 | 130 | 97 | 113.46 | 106.61 | 6.43% |
| 2020-07-20 | 13 | 120 | 90 | 104.85 | 102.29 | 2.5% |
| 2020-07-18 | 13 | 120 | 90 | 104.54 | 101.98 | 2.51% |
| 2020-06-29 | 13 | 120 | 90 | 103.15 | NA | NA% |
| 2020-06-23 | 12 | 120 | 90 | 103.42 | NA | NA% |
| 2020-06-17 | 12 | 120 | 90 | 102.33 | NA | NA% |
| 2020-05-04 | 12 | 118 | 90 | 101.08 | NA | NA% |
PRAH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 5 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
PRAH's average broker recommendation rating worsened by 0.2 over the prior 91 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The average analyst price target of PRAH is higher than 91.75% of all US stocks.
- PRA Health Sciences Inc's variance in analysts' estimates is less than 96.83% of stocks in the large market cap category.
- The number of analysts covering the stock of PRAH is greater than 6.63% of stocks in the large market cap category.
- The upside potential (average analyst target price relative to current price) of PRAH is greater than 10.69% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Business Services industry with the ratings most similar to PRA Health Sciences Inc are APPF, APPN and CDLX.
Make investment decisions regarding PRAH using the data that counts. Try POWR Ratings for free.